Cargando…
Changing the paradigm: the potential for targeted therapy in laryngeal squamous cell carcinoma
Laryngeal squamous cell carcinoma (LSCC) remains a highly morbid and fatal disease. Historically, it has been a model example for organ preservation and treatment stratification paradigms. Unfortunately, survival for LSCC has stagnated over the past few decades. As the era of next-generation sequenc...
Autores principales: | Ludwig, Megan L., Birkeland, Andrew C., Hoesli, Rebecca, Swiecicki, Paul, Spector, Matthew E., Brenner, J. Chad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chinese Anti-Cancer Association
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4850131/ https://www.ncbi.nlm.nih.gov/pubmed/27144065 http://dx.doi.org/10.28092/j.issn.2095-3941.2016.0010 |
Ejemplares similares
-
Prognostic Significance of Oxidation Pathway Mutations in Recurrent Laryngeal Squamous Cell Carcinoma
por: Heft Neal, Molly E., et al.
Publicado: (2020) -
Window of opportunity trials in head and neck cancer
por: Farlow, Janice L., et al.
Publicado: (2019) -
Small molecule profiling to define synergistic EGFR inhibitor combinations in head and neck squamous cell carcinoma
por: Michmerhuizen, Nicole L., et al.
Publicado: (2022) -
Genetic determinants in head and neck squamous cell carcinoma and their influence on global personalized medicine
por: Michmerhuizen, Nicole L., et al.
Publicado: (2016) -
ITGA5 is an independent prognostic biomarker and potential therapeutic target for laryngeal squamous cell carcinoma
por: Zhou, Chongchang, et al.
Publicado: (2022)